IG-001

· Sorrento Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IG-001, covering 2016-03-25 to 2016-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer [NA]